Molina Healthcare Stock Hits New 52-Week High (MOH)
Molina Healthcare (NYSE:MOH) hit a new 52-week high Thursday as it is currently trading at $34.30, above its previous 52-week high of $34.28 with 473,405 shares traded as of 2:15 p.m. ET. Average volume has been 899,900 shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Molina Healthcare (NYSE: MOH) hit a new 52-week high Thursday as it is currently trading at $34.30, above its previous 52-week high of $34.28 with 473,405 shares traded as of 2:15 p.m. ET. Average volume has been 899,900 shares over the past 30 days. Molina Healthcare has a market cap of $1.51 billion and is part of the health care sector and health services industry. Shares are up 22.5% year to date as of the close of trading on Wednesday. Molina Healthcare, Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals, as well as to assist state agencies in their administration of the Medicaid program. The company has a P/E ratio of 72.2, above the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates Molina Healthcare as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full Molina Healthcare Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.